<DOC>
	<DOCNO>NCT00996242</DOCNO>
	<brief_summary>The objective present study investigate possibility use L-lysine , amino acid occur naturally food interferes nitric oxide ( NO ) production , treatment schizophrenia . L-lysine , 6 g/day , administer ten patient schizophrenia add-on treatment conventional antipsychotic treatment . The study design single-blinded , cross-over study patient randomly assign initial treatment either L-lysine placebo screen baseline , four week treatment cross , eight week treatment terminate . The four-week L-lysine treatment regimen cause significant increase blood concentration amino acid tolerate well . The analysis outcome measure show significant decrease symptom severity measure Positive Negative Syndrome Scale ( PANSS ) . Furthermore , patient 's ability solve Wisconsin Card Sorting Task ( WCST ) significantly improve indicating increase problem solve capacity cognitive flexibility . Subjective report three patient also indicate decreased symptom severity enhance cognitive functioning . In summary , finding suggest potential beneficial effect L-lysine treatment symptom severity cognitive deficit patient schizophrenia .</brief_summary>
	<brief_title>An Exploratory Open Label Study Adjunctive L-lysine Treatment Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>stable phase illness stable dose antipsychotic medication major medical condition psychiatric diagnosis normal admission laboratory test vital sign substance abuse , apart smoke</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>56 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>L-lysine</keyword>
	<keyword>PANSS</keyword>
</DOC>